CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
SUMCASTEC aims to revolutionize cancer treatment by developing a micro-optofluidic lab-on-chip platform for rapid isolation and neutralization of cancer stem cells. This technology will enable real-time monitoring and manipulation of cell environments, potentially improving therapies for aggressive brain cancers.
SUMCASTEC explores radically new approach for cancer stem cells (CSCs) real time isolation (i.e. within minutes vs current 40 days) and neutralization. A novel micro-optofluidic lab-on-chip (LOC) platform will be developed through a joint and iterative effort by biologists, clinicians and engineers.
For the first time, a single LOC will be capable of delivering ultra-wide broadband radiation to compare cell spectral signatures, image subcellular features, and hence modulate CSCs microenvironment…
UNIVERSITE DE LIMOGES
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
United Kingdom, Bangor
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
LEIBNIZ-INSTITUT FUR INNOVATIVE MIKROELEKTRONIK
Germany, Frankfurt Oder
Type: Research institute
Activity type: Research Organisations
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
